BACTERICIDAL INTERACTIONS OF A BETA-LACTAM AND BETA-LACTAMASE INHIBITORS IN EXPERIMENTAL PSEUDOMONAS-AERUGINOSA ENDOCARDITIS CAUSED BY A CONSTITUTIVE OVERPRODUCER OF TYPE-ID BETA-LACTAMASE

被引：11

作者：

BAYER, AS

SELECKY, M

BABEL, K

HIRANO, L

YIH, J

PARR, TR

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024

[2] UNIV OTTAWA,SCH MED,DEPT MICROBIOL & IMMUNOL,OTTAWA K1N 6N5,ONTARIO,CANADA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1987年 / 31卷 / 11期

关键词：

D O I：

10.1128/AAC.31.11.1750

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1750 / 1755

页数：6

共 32 条

[1] ROLE OF BETA-LACTAMASE IN INVIVO DEVELOPMENT OF CEFTAZIDIME RESISTANCE IN EXPERIMENTAL PSEUDOMONAS-AERUGINOSA ENDOCARDITIS
BAYER, AS
PETERS, J
PARR, TR
CHAN, L
HANCOCK, REW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 253 - 258
[2] EFFICACY OF AMIKACIN AND CEFTAZIDIME IN EXPERIMENTAL AORTIC-VALVE ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA
BAYER, AS
NORMAN, D
KIM, KS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) : 781 - 785
[3] CHARACTERIZATION OF IMPERMEABILITY VARIANTS OF PSEUDOMONAS-AERUGINOSA ISOLATED DURING UNSUCCESSFUL THERAPY OF EXPERIMENTAL ENDOCARDITIS
BAYER, AS
NORMAN, DC
KIM, KS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 70 - 75
[4] ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN RABBITS - EXPRESSION OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS INVIVO AND INVITRO
CHAMBERS, HF
HACKBARTH, CJ
DRAKE, TA
RUSNAK, MG
SANDE, MA
[J]. JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06) : 894 - 903
[5] THERAPY OF EXPERIMENTAL PSEUDOMONAS ENDOCARDITIS WITH HIGH-DOSE AMIKACIN AND TICARCILLIN
CHOI, C
BAYER, AS
FUJITA, NK
LAM, K
GUZE, LB
YOSHIKAWA, TT
[J]. CHEMOTHERAPY, 1983, 29 (04) : 303 - 312
[6] ACTIVITY OF CEFOPERAZONE AND 2 BETA-LACTAMASE INHIBITORS, SULBACTAM AND CLAVULANIC ACID, AGAINST BACTEROIDES SPP CORRELATED WITH BETA-LACTAMASE PRODUCTION
CROSBY, MA
GUMP, DW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) : 398 - 405
[7] Dixon M., 1979, ENZYMES
[8] TIMENTIN VERSUS PIPERACILLIN OR MOXALACTAM IN THE THERAPY OF ACUTE BACTERIAL-INFECTIONS
FILE, TM
TAN, JS
SALSTROM, SJ
JOHNSON, LA
DOUGLAS, GF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (03) : 310 - 313
[9] FISHER JF, 1980, ENZYME INHIBITORS DR, P209
[10] PHARMACOKINETICS OF SULBACTAM IN HUMANS
FOULDS, G
STANKEWICH, JP
MARSHALL, DC
OBRIEN, MM
HAYES, SL
WEIDLER, DJ
MCMAHON, FG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 692 - 699

← 1 2 3 4 →